ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Growth-Insured vs Nippon India Nifty Pharma ETF - Growth Plan
NAV, returns and costs — not a recommendation.
 ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Growth-Insured |  Nippon India Nifty Pharma ETF - Growth Plan | |
|---|---|---|
| NAV | ₹43.43 | ₹27.1122 |
| NAV date | 2026-08-18 | 2026-08-18 |
| 1 year | +7.31% | +19.49% |
| 3 year (p.a.) | +22.09% | +20.35% |
| 5 year (p.a.) | +15.97% | +14.55% |
| Expense ratio | 1.56% | 0.18% |
| Fund size | ₹6,624.58 Cr | ₹1,622.31 Cr |
| Risk | Very high | Very high |
| Category | Sectoral Pharma and Healthcare | Etfs |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.